advertisement

---

Arif R 11

Showing records 1 to 11 | Display all abstracts from Arif R

125986 Drug repurposing: Identification and X-ray crystallographic analyses of US-FDA approved drugs against carbonic anhydrase-II
Rasheed S
International Journal of Biological Macromolecules 2025; 305: 141057

---

126068 Identification of new 1,2,3-Triazole analogues of sulfanilamide as inhibitors of the carbonic anhydrase II enzyme: Comprehensive in-vitro and in-vivo analyses
Malik A
International Journal of Biological Macromolecules 2025; 303: 140426

---

125986 Drug repurposing: Identification and X-ray crystallographic analyses of US-FDA approved drugs against carbonic anhydrase-II
Huda NR
International Journal of Biological Macromolecules 2025; 305: 141057

---

126068 Identification of new 1,2,3-Triazole analogues of sulfanilamide as inhibitors of the carbonic anhydrase II enzyme: Comprehensive in-vitro and in-vivo analyses
Huda NU; Tahir SS
International Journal of Biological Macromolecules 2025; 303: 140426

---

125986 Drug repurposing: Identification and X-ray crystallographic analyses of US-FDA approved drugs against carbonic anhydrase-II
Warsi Z; Tahir SS
International Journal of Biological Macromolecules 2025; 305: 141057

---

126068 Identification of new 1,2,3-Triazole analogues of sulfanilamide as inhibitors of the carbonic anhydrase II enzyme: Comprehensive in-vitro and in-vivo analyses
Warsi Z
International Journal of Biological Macromolecules 2025; 303: 140426

---

125986 Drug repurposing: Identification and X-ray crystallographic analyses of US-FDA approved drugs against carbonic anhydrase-II
Ahmad MS
International Journal of Biological Macromolecules 2025; 305: 141057

---

126068 Identification of new 1,2,3-Triazole analogues of sulfanilamide as inhibitors of the carbonic anhydrase II enzyme: Comprehensive in-vitro and in-vivo analyses
Arif R; Khan MA
International Journal of Biological Macromolecules 2025; 303: 140426

---

125986 Drug repurposing: Identification and X-ray crystallographic analyses of US-FDA approved drugs against carbonic anhydrase-II
Gul S; Arif R
International Journal of Biological Macromolecules 2025; 305: 141057

---

126068 Identification of new 1,2,3-Triazole analogues of sulfanilamide as inhibitors of the carbonic anhydrase II enzyme: Comprehensive in-vitro and in-vivo analyses
Rasheed S
International Journal of Biological Macromolecules 2025; 303: 140426

---

125986 Drug repurposing: Identification and X-ray crystallographic analyses of US-FDA approved drugs against carbonic anhydrase-II
Falke S
International Journal of Biological Macromolecules 2025; 305: 141057

---